A Phase I/II Pharmacokinetic and Pharmacodynamic Study of ABT-751 in Combination With Carboplatin in Patients With Advanced Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 01 May 2009
At a glance
- Drugs ABT 751; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 01 May 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Sep 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.